1.40
Adc Therapeutics Sa (ADCT) 最新ニュース
ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis - Seeking Alpha
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements - PR Newswire
Adc Therapeutics Sa (ADCT-N) Stock Price and News - The Globe and Mail
ADC Therapeutics SA (ADCT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare ConferenceSlideshow - Seeking Alpha
ADC Therapeutics SA (NYSE:ADCT) Receives Average Recommendation of "Hold" from Brokerages - marketbeat.com
ADC Therapeutics SA (ADCT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare ConferenceSlideshow - Seeking Alpha
ADC Therapeutics at Cantor conference: zynlonta growth plan faces FDA test - Investing.com Nigeria
ADCT: ZYNLONTA shows high response rates and regulatory momentum in DLBCL and lymphoma studies - TradingView
ADCT: Promising LOTIS-7 results and robust cash position support expansion in lymphoma markets - TradingView
ADC Therapeutics at Cantor conference: zynlonta growth plan faces FDA test - Investing.com India
ADC Therapeutics at Cantor conference: zynlonta growth plan faces FDA test - Investing.com UK
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.9%Time to Sell? - marketbeat.com
ADC Therapeutics SA (ADCT) Stock Price & News - Syfe
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - morningstar.com
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - PR Newswire
ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses - Yahoo Finance
ADC Therapeutics SA (ADCT) Stock News Today - TradingKey
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript - AOL.com
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Following a 56% Decline Over Last Year, Recent Gains May Please ADC Therapeutics SA (NYSE:ADCT) Institutional Owners - 富途牛牛
Guggenheim cuts ADC Therapeutics stock price target on FDA concerns By Investing.com - Investing.com South Africa
Guggenheim cuts ADC Therapeutics stock price target on FDA concerns By Investing.com - Investing.com UK
Antibody-Drug Conjugates (ADC) Market Set to Witness Significant - The National Law Review
ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook - Yahoo Finance
ADC Therapeutics (NYSE:ADCT) Rating Increased to Hold at Wall Street Zen - MarketBeat
Nantahala group discloses 9.69% ADC Therapeutics (ADCT) ownership in 13G filing - Stock Titan
ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says - marketscreener.com
ADC Therapeutics S.A. Q2 2026 Earnings Call Summary - Yahoo Finance
ADC Therapeutics SA (ADCT) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles ... - Yahoo! Finance Canada
ADC Therapeutics Q2 Earnings Call Highlights - MarketBeat
ADC Therapeutics Q2 Earnings Call Highlights - Yahoo Finance
ADC Therapeutics (NYSE:ADCT) Posts Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
ADC Therapeutics SA: Shareholders Board Members Managers and Company Profile | CH0499880968 - marketscreener.com
ADC Therapeutics Q2 Results: Net Loss Falls 71% to $16.6 Million - scanx.trade
Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com Nigeria
Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com Australia
Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com South Africa
ADC Therapeutics SA reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com India
Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com Canada
Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com UK
ADC Therapeutics SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings call transcript: ADC Therapeutics beats Q2 2026 estimates but shares fall - Investing.com
ADC Therapeutics Q2 2026 Earnings Call Transcript - Benzinga
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
ADC THERAPEUTICS SA -REDH ($ADCT) Releases Q2 2026 Earnings - Moomoo
ADC THERAPEUTICS SA -REDH ($ADCT) Releases Q2 2026 Earnings | ADCT Stock News - Quiver Quantitative
ADC Therapeutics Q2 2026 Earnings: Lower Spending Narrows the Loss - TradingKey
ADC Therapeutics SA (ADCT) Latest Stock News & Headlines - Yahoo Finance
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates - Yahoo Finance
大文字化:
|
ボリューム (24 時間):